Lyra TherapeuticsLYRA

13F holders, Q1 2025 (March 31)
57holders +3
6new positions
3sold out
1famous investor
$0.13avg. 13F price*

At the end of Q1 2025, 57 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings, up 3 from Q4 2024. 6 opened new positions and 3 sold out. The largest holders were Perceptive Advisors LLC ($1.6M), BlackRock, Inc. ($381K) and Vanguard Group Inc. ($222K). One famous investor held it Cliff Asness (0.0% of AQR Capital Management's portfolio).

Company
Lyra Therapeutics Inc.
CUSIP
55234L105
Latest filing quarter
Q2 2025

History

Number of 13F holders

020406080 Q1 2024: 79Q1 2024Q2 2024: 51Q2 2024Q3 2024: 62Q3 2024Q4 2024: 54Q4 2024Q1 2025: 57Q1 2025Q2 2025: 1Q2 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions6$13K
Exits3$91K

All 13F filers, Q4 2024 → Q1 2025: 498,096 shares bought and 1,788,805 shares sold, net −1,290,709 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 57 holders

Perceptive Advisors LLC 0.06% No change 12,757,562 $1.6M
BlackRock, Inc. 0.00% Reduce -2.9% 3,018,986 $381K
Vanguard Group Inc. 0.00% Reduce -1.2% 1,765,585 $222K
Samsara Biocapital, LLC 0.03% Reduce -29.3% 1,390,130 $176K
Ikarian Capital, LLC 0.04% No change 1,058,148 $134K
Geode Capital Management, LLC 0.00% Add +14.7% 1,016,004 $128K
ADAR1 Capital Management, LLC 0.01% No change 533,200 $67K
State Street Corp. 0.00% No change 488,720 $62K
UBS Group AG 0.00% Add +2.2% 434,226 $55K
Goldman Sachs Group Inc. 0.00% Reduce -33.4% 370,194 $47K
Two Sigma Advisers, LP 0.00% Reduce -5.5% 364,478 $46K
Northern Trust Corp. 0.00% Add +16.2% 332,639 $42K
BNP Paribas Financial Markets 0.00% Reduce -1.0% 242,546 $31K
Boothbay Fund Management, LLC 0.00% No change 233,989 $30K
Susquehanna International Group, LLP 0.00% Add +110.3% 217,567 $27K
Two Sigma Investments, LP 0.00% Reduce -8.0% 193,145 $24K
New York State Common Retirement Fund 0.00% No change 154,800 $20K
Charles Schwab Investment Management Inc. 0.00% No change 111,609 $14K
Rhumbline Advisers 0.00% Add +112.6% 87,710 $11K
Bank of New York Mellon Corp 0.00% Reduce -5.8% 71,585 $9K
Morgan Stanley 0.00% Reduce -69.7% 65,619 $8K
FMR LLC 0.00% Reduce -41.7% 58,213 $7K
AQR Capital Management 0.00% Add +102.1% 58,041 $7K
JPMorgan Chase & Co. 0.00% Reduce -64.0% 56,277 $7K
Tower Research Capital LLC (TRC) 0.00% Add +32.5% 52,736 $7K
Barclays PLC 0.00% Reduce -33.5% 50,038 $6K
Jane Street Group, LLC 0.00% New 43,997 $6K
Citigroup Inc. 0.00% Reduce -7.7% 35,177 $4K
Alliancebernstein L.P. 0.00% No change 33,120 $4K
Sei Investments Co. 0.00% Reduce -64.2% 30,067 $4K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% Add +4.5% 29,018 $4K
Wells Fargo & Company 0.00% Add +2.3% 25,305 $3K
T. Rowe Price Associates Inc. 0.00% No change 17,541 $3K
Corebridge Financial, Inc. 0.00% Reduce -1.5% 23,709 $3K
Invesco Ltd. 0.00% No change 23,626 $3K
Bank of America Corp. 0.00% Reduce -59.5% 21,352 $3K
Intech Investment Management LLC 0.00% New 16,560 $2K
SG Americas Securities, LLC 0.00% Reduce -54.2% 14,620 $2K
Squarepoint Ops LLC 0.00% New 15,283 $2K
Abel Hall, LLC 0.00% Reduce -30.8% 12,214 $2K
Cibc World Markets Corp. 0.00% New 10,739 $1K
ProShare Advisors LLC 0.00% Reduce -23.1% 10,477 $1K
Sassicaia Capital Advisers LLC 0.00% New 10,000 $1K
Royal Bank of Canada 0.00% Add +51.5% 8,019 $1K
Cwm, LLC 0.00% Add +24.3% 6,677 $1K
Northwestern Mutual Wealth Management Co. 0.00% New 6,000 $758
Ameritas Investment Partners, Inc. 0.00% No change 4,741 $599
SBI Securities Co., Ltd. 0.00% Add +0.1% 4,272 $540
California State Teachers Retirement System 0.00% No change 3,507 $443
Comerica Bank 0.00% No change 1,159 $146
Wilmington Savings Fund Society, FSB 0.00% No change 1,025 $129
Jones Financial Companies LLLP 0.00% No change 500 $69
Nisa Investment Advisors, LLC 0.00% No change 500 $63
EverSource Wealth Advisors, LLC 0.00% Add +188.2% 343 $43
Sterling Capital Management LLC 0.00% No change 88 $11
Amalgamated Bank 0.00% No change 1,674 $0
Simplex Trading, LLC 0.00% Add +262.8% 1,317 $0

"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.